Moleculin Biotech (MBRX) Tops Q1 EPS by 1c

Moleculin Biotech (NASDAQ: MBRX) reported Q1 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.

You May Also Be Interested In

• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• Nebius Group plans $4.5B convertible notes offering in two series
• Kingsoft Cloud Holdings Limited (KC) Tops Q2 EPS by 40c